Edgewise Therapeutics, Inc.

Direct answer

Edgewise Therapeutics, Inc. is publicly traded on NASDAQ under the ticker EWTX.

Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully concluded its Phase 1...

Can you invest in Edgewise Therapeutics, Inc.?

Yes. Edgewise Therapeutics, Inc. trades publicly on NASDAQ as EWTX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Edgewise Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.